✦ The floor
Discussion
Signed responses from readers of the wire.
✦ Clinical Takeaway ✦
No actionable change — this is an author correspondence reply and should be read alongside the original JAMA article and any related letters for full context.
✦ Why It Matters ✦
Author replies in high-impact journals can clarify methodological choices and limitations, shaping how the original findings are interpreted by clinicians and policymakers.
✦ Key Points ✦
- 01Author reply to correspondence in JAMA (PMID 42766307) on hearing aids for mild to moderate hearing loss.
- 02No new primary data; responds to critiques or questions raised by readers.
- 03Full text not yet available ahead of print — content unknown.
- 04Should be read in conjunction with the original article (PMID 42766286) for complete context.
✦ Research metadata ✦
- PMID
- 42766307
- DOI
- 10.1001/jama.2026.14627.
- Journal
- JAMA
- Publication type
- editorial
- Evidence level
- 5
- Population
- Adults with mild to moderate hearing loss
- Intervention
- Hearing aids
Primary outcomes
Author clarification of original study findings